New Alzheimer's Study Seeks To Find Earliest Clues To Disease Progression
Main Category: Alzheimer's / DementiaArticle Date: 26 Aug 2010 - 0:00 PDT
| Patient / Public: | ![]() |
4 (1 votes) |
| Healthcare Prof: | ![]() |
3 (1 votes) |
Today, 5.3 million Americans are suffering from Alzheimer's disease (AD), and every 70 seconds, another person develops this devastating disease. These numbers will continue to increase with our aging population unless new prevention and treatment strategies are discovered. A study funded by the National Institute on Aging (NIA) at the National Institutes of Health (NIH) may help provide some answers. This two-year, $24 million study -- the Alzheimer's Disease Neuroimaging Initiative Grand Opportunity (ADNI GO) -- focuses for the first time on people experiencing the very earliest complaints of memory problems that affect their daily activities. ADNI GO expands on the groundbreaking Alzheimer's Disease Neuroimaging Initiative (ADNI) and will continue efforts to identify biomarkers that can help build a greater understanding of the progression of AD.
"ADNI GO is helping us determine the sequence and timing of events at the initial onset of mild symptoms," said Paul Aisen, M.D., director of the Alzheimer's Disease Cooperative Study (ADCS). "It is our hope that this research will enable us to better identify who is at risk, as well as the effectiveness of potential prevention and treatment strategies."
Many people view memory loss as an unavoidable aspect of aging, but memory loss that disrupts daily life is not a normal part of growing older. ADNI GO researchers are looking for participants between the ages of 55 and 90 who are otherwise healthy, but may be experiencing signs of early stage of amnestic mild cognitive impairment (aMCI), a condition that may lead to Alzheimer's disease.
"We cannot end this terrible disease unless we know more about it," said Dr. Aisen. "That is where the amazing volunteers, their friends and their families can make the difference in our success."
Source:
ADNI GO
Visit our alzheimer's / dementia section for the latest news on this subject.
MLA
11 Feb. 2012. <http://www.medicalnewstoday.com/releases/198896.php>
APA
http://www.medicalnewstoday.com/releases/198896.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.






